Halozyme Therapeutics Inc. buy geldnutzer
Start price
16.09.24
/
70%
€56.30
Target price
16.09.25
€74.00
Performance (%)
13.04%
End price
17.09.25
€63.64
Summary
This prediction ended on 17.09.25 with a price of €63.64. The BUY prediction by geldnutzer finished with a performance of 13.04%. geldnutzer has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Halozyme Therapeutics Inc. | -2.574% | -2.574% | 15.872% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
According to geldnutzer what are the pros and cons of Halozyme Therapeutics Inc. for the foreseeable future?
Pros
Revenue growth >5% per year expected
Some uniques
Sustainability is important
Medium risks for its business
Future proof or reliable business model
Fair valuation
ROE higher than 10% per year
Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Good rating
Standard Investments for future growth
Valuable balance sheet
Normal challenges to pay loans and raise capital
Capable Management
Good culture
Innovative
Cons
Low dividend yield expected
Dependend from some customers or products
Growths slower than the competition
Significant cyclical dependencies
Little known brand
high free float
negative Cash Flow expected
Below average Marketposition
Comments by geldnutzer for this prediction
In the thread Halozyme Therapeu. diskutieren
Kursziel geändert auf 52,0
Kursziel geändert auf 58,0
Kursziel geändert auf 59,0
Kursziel geändert auf 49,0
Kursziel geändert auf 54,0
Kursziel geändert auf 74,0
In the thread Trading Halozyme Therapeutics Inc.
Die von geldnutzer gewählte maximale Laufzeit wurde überschritten